Remission of Recurrent Endometrial Cancer with Hormonal Therapy : Case Report and Review of Literature

Article Sidebar

Fulltext
Published: Jul 1, 1996
Keywords:
recurrent endometrial cancer hormonal therapy

Main Article Content

Surintip Piamsomboon
Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Wichai Termrungruanglert
Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Andrzej P Kudelka
The University of Texas M.D. Anderson Cancer Centre, Houston, Texas, US
Vitaya Titapant
Department of Obstetrics and Gynecology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Creighton L Edwards
The University of Texas M.D. Anderson Cancer Centre, Houston, Texas, US
John W Whitt
Gulf Coast Cancer Centre, Wharton, Texas, US
John J Kavanagh
The University of Texas M.D. Anderson Cancer Centre, Houston, Texas, US

Abstract

A case of stage II endometrial cancer which had recurred after radiotherapy and hysterectomy was manipulated with hormonal therapy. Oral megestrol acetate 160 mg per day induced partial response of measurable lesion. The duration of response was appreciated, 41 months. Later tamoxifen 40 mg per day orally also stabilized the progressive disease for another 18 months. Hormonal therapy has modest activity, low toxicity and should be considered in selected case of recurrent endometrial cancer

Article Details

How to Cite
(1)
Piamsomboon, S. .; Termrungruanglert, W. .; P Kudelka, A. .; Titapant , V. .; L Edwards, C.; W Whitt, J.; J Kavanagh, J. Remission of Recurrent Endometrial Cancer With Hormonal Therapy : Case Report and Review of Literature. Thai J Obstet Gynaecol 1996, 8, 257-261.
Issue
VOL. 8, NO. 3: (July - September 1996)
Section
Case Report
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.